R
Raffaella Vergura
Researcher at University of Ferrara
Publications - 9
Citations - 477
Raffaella Vergura is an academic researcher from University of Ferrara. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 7, co-authored 9 publications receiving 458 citations.
Papers
More filters
Journal ArticleDOI
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice
Anna Rizzi,Raffaella Vergura,Giuliano Marzola,Chiara Ruzza,Remo Guerrini,Severo Salvadori,Domenico Regoli,Girolamo Calo +7 more
TL;DR: The effects of in vivo supraspinal NPS in mice are evaluated and it is shown that in vivo NPS produces a unique behavioural profile by increasing wakefulness and exerting anxiolytic‐like effects.
Journal ArticleDOI
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
Adelheid Roth,Erika Marzola,Anna Rizzi,Marika Arduin,Claudio Trapella,Corrado Corti,Raffaella Vergura,Prisca Martinelli,Severo Salvadori,Domenico Regoli,Mauro Corsi,Paolo Cavanni,Girolamo Calo,Remo Guerrini +13 more
TL;DR: This study identified the amino acid residues of this peptide most important for receptor activation as Thr8-Gly9-Met10, suggesting that the C-terminal region of the peptide maintains importance for in vivo activity.
Journal ArticleDOI
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
Raffaella Vergura,Gianfranco Balboni,Gianfranco Balboni,Barbara Spagnolo,Elaine C. Gavioli,David G. Lambert,John McDonald,Claudio Trapella,Lawrence H. Lazarus,Domenico Regoli,Remo Guerrini,Severo Salvadori,Girolamo Calo +12 more
TL;DR: The present findings demonstrate that UFP-512 behaves as a highly potent and selective agonist at Dop receptors and corroborate the proposal that the selective activation of DOP receptors elicits robust anxiolytic- and antidepressant-like effects in rodents.
Journal ArticleDOI
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.
TL;DR: It is demonstrated that N/OFQ stimulates human monocyte chemotaxis via NOP receptor activation through the order of potency of agonists and the antagonist selectivity.
Journal ArticleDOI
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP-803)
Valeria Camarda,Martina Spagnol,Wei Song,Raffaella Vergura,Adelheid Roth,Jonathan P. Thompson,David J. Rowbotham,Remo Guerrini,Erika Marzola,Severo Salvadori,Paolo Cavanni,Domenico Regoli,Stephen A. Douglas,David G. Lambert,Girolamo Calo +14 more
TL;DR: UFP‐803 is a potent UT receptor ligand which displays competitive/noncompetitive antagonist behavior depending on the assay, and is less potent than urantide, which displayed reduced residual agonist activity and as such may be a useful pharmacological tool.